Join us at the 2023 Discovery on Target conference–the industry’s preeminent event on novel drug targets and technologies.
Science director, Zack Gurard-Levin, Ph.D. will be presenting a scientific poster showcasing high-throughput affinity selection mass spec assay to discover small molecule ligands for cell surface receptors.
If you would like to learn more about our innovative approach to drug discovery, including label-free and high-throughput SAMDI-MS technology, fill out the form to schedule time to meet with us.
We look forward to seeing you in Boston!